BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update

  Monopar Therapeutics Inc. today announced an update from its currently enrolling multi-center open-label Phase 1b clinical trial of camsirubicin in patients with advanced soft tissue sarcoma (ASTS).

  June 1, 2023

   · 

  5 min read
• Pharm Country

  atai Life Sciences to Participate in Upcoming June Investor Conferences

  atai Life Sciences will participate in upcoming June Investor Conferences. Details of the company’s participation are as follows.

  June 1, 2023

   · 

  1 min read
• Bio NC

  Milestone Pharmaceuticals to Present at the Jefferies Healthcare Conference - June 1, 2023

  Milestone Pharmaceuticals Inc. today announced that members of its management team will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 8:30 a.m. ET.

  June 1, 2023

   · 

  1 min read
• Seegene Obtains IVDR Certification for 30 Diagnostic Assays

  Seegene Inc. announced today that it has obtained the European Union’s In Vitro Diagnostic Medical Device Regulation (IVDR) certification for 30 diagnostic assays.

  June 1, 2023

   · 

  1 min read
• Biotech Beach

  Abilita Bio Changes Name to Abilita Therapeutics and Appoints Joel Edwards as Chief Business Officer

  Abilita Bio, a leader in enabling the discovery of membrane protein-targeted therapeutics, announced today the company changed its name to Abilita Therapeutics.

  June 1, 2023

   · 

  3 min read
• Genetown

  Karyopharm to Participate at the Jefferies Healthcare Conference

  Karyopharm Therapeutics Inc. today announced that the Company’s senior management team will participate at the Jefferies Healthcare Conference in a fireside chat on Thursday, June 8, 2023 at 10:00 a.m. ET in New York, NY.

  June 1, 2023

   · 

  1 min read
• ESSA Pharma to Present at 2023 Jefferies Healthcare Conference

  ESSA Pharma Inc. today announced that the Company will be presenting at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 8:00 a.m. Eastern Time in New York.

  June 1, 2023

   · 

  1 min read
• Biotech Beach

  Ionis announces positive donidalorsen late-stage clinical progress in HAE

  Ionis Pharmaceuticals, Inc . (Nasdaq: IONS) today announced positive clinical progress with donidalorsen, its late-stage investigational prophylactic therapy for hereditary angioedema (HAE).

  June 1, 2023

   · 

  5 min read
• BioCapital

  REGENXBIO Announces Presentation at the Jefferies Global Healthcare Conference

  REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will present and host one-on-one investor meetings at the Jefferies Global Healthcare Conference on Thursday, June 8, 2023.

  June 1, 2023

   · 

  1 min read
• Novocure Pledges $3 Million to Conquer Cancer®, the ASCO Foundation, to Support Cancer Research and Education

  Novocure Pledges $3 Million to Conquer Cancer ® , the ASCO Foundation, to Support Cancer Research and Education.

  June 1, 2023

   · 

  4 min read